24小时热门版块排行榜    

查看: 3502  |  回复: 14

letdd

新虫 (初入文坛)

[交流] JPBA 投稿被拒,贴出拒稿信,求指点 已有5人参与

Dear Dr. Zhu,

I regret to inform you that, after consideration of our reviewers' comments on your paper (with which I fully agree), I'm unable to accept it for publication.

For your guidance, I append the reviewers' comments below.

Please note that a great many more papers are submitted to JPBA than we can possibly publish. The acceptance rate for papers is about 25% and our decision is not a reflection of the quality of your research but rather of our stringent requirements.

The Editors hope that you do understand the above decision, and we appreciate your continued interest in the Journal of Pharmaceutical and Biomedical Analysis.

Thank you for giving us the opportunity to consider your work. We wish you every success when you submit the paper elsewhere.

Yours sincerely,

Sándor Görög
Editor
Journal of Pharmaceutical and Biomedical Analysis

Reviewers' comments:


Reviewer #1: This paper is about Identification of major compounds in rat bile, plasma and urine after oral administration of Radix Scutellariae extract by ultra-fast liquid chromatography coupled to ion trap time-of-flight mass spectrometry.
Although these observation are interesting, they are rather limited and do not advance our knowledge of the subject sufficiently to warrant publication in JPBA.
1.        It is noted that your manuscript needs careful editing by someone with expertise in technical English editing paying particular attention to English grammar, spelling, and sentence structure.
2.        The innovation of this manuscript is weak and the content of experiments is not plentiful.
3.        The Fig.4 and Fig.4 are not clearly expressed, and the Fig.5 should be deleted. It will be nice if you can add the schematic diagram of the cracking.
Based on what was described above this manuscript is not suitable for publication in the journal of JPBA. We suggest that the authors try submitting their findings to other journals.




Reviewer #2: I do not recommend the publication of this manuscript due mainly to the lack of scientific novelty and for neglecting the comparison of the authors' method and results with those in the literature. The Guide for Authors of JPBA contains the following restriction: "In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods."
The authors have missed to make reference to closely related papers such as
Ling Tong, Meixu Wan, Lihua Zhang, Yonghong Zhu, He Sun, Kaishun Bi,  Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis (2012) (from the same university!!!) and
Chung, H.J., Lim, S., Kim, I.S., Bu, Y., Kim, H., Kim, D.-H., Yoo, H.H., Simultaneous determination of baicalein, baicalin, wogonin, and wogonoside in rat plasma by LC-MS/MS for studying the pharmacokinetics of the standardized extract of scutellariae radix, Bulletin of the Korean Chemical Society,  33 (2012) 177-182.
Reference has been made to [23] but real comparison was not made.
回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐,对您同样有帮助:

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

独步青云

新虫 (职业作家)

术中小生


小木虫: 金币+0.5, 给个红包,谢谢回帖
我仔细看了审稿意见。
首先不要再投JPBA了,通过几点老鼠,利用LC/MS进行简单地鉴定入血成分,自去年JPBA就不收了。随着IF的增长,其在代谢方面要求显著提高。
审稿人认为你的方法没有什么特色,换句话说你的发现没有什么闪光点。另外一定得和已报道文献进行比对,说明你方法的先进性。任何文章只报道自己东西,没有和先前文献对比的话,肯定是一短板。尤其遇到做过相关研究的审稿人,他认变你没有好好看文献。
2楼2012-09-02 12:46:48
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

letdd

新虫 (初入文坛)

引用回帖:
2楼: Originally posted by 独步青云 at 2012-09-02 12:46:48
我仔细看了审稿意见。
首先不要再投JPBA了,通过几点老鼠,利用LC/MS进行简单地鉴定入血成分,自去年JPBA就不收了。随着IF的增长,其在代谢方面要求显著提高。
审稿人认为你的方法没有什么特色,换句话说你的发现 ...

可能标题有误导,我做的代谢产物结构鉴定的。鉴定了20种代谢产物。和10种入血成分。
3楼2012-09-06 13:26:40
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

独步青云

新虫 (职业作家)

术中小生


小木虫: 金币+0.5, 给个红包,谢谢回帖
引用回帖:
3楼: Originally posted by letdd at 2012-09-06 13:26:40
可能标题有误导,我做的代谢产物结构鉴定的。鉴定了20种代谢产物。和10种入血成分。...

我没有被误解。像黄芩做这以多,你鉴定的结果也没有多大的突破。如果我是审稿人也会拒这方面的文章。是文章的要求高了,没有办法。换在两年前还是可以的。
4楼2012-09-06 15:04:30
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

letdd

新虫 (初入文坛)

引用回帖:
4楼: Originally posted by 独步青云 at 2012-09-06 15:04:30
我没有被误解。像黄芩做这以多,你鉴定的结果也没有多大的突破。如果我是审稿人也会拒这方面的文章。是文章的要求高了,没有办法。换在两年前还是可以的。...

这样哦。哎。。那我只能换杂志了,你觉得Biomedical chromatography 1.9有可能接受吗?
5楼2012-09-07 19:56:03
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

独步青云

新虫 (职业作家)

术中小生


小木虫: 金币+0.5, 给个红包,谢谢回帖
引用回帖:
5楼: Originally posted by letdd at 2012-09-07 19:56:03
这样哦。哎。。那我只能换杂志了,你觉得Biomedical chromatography 1.9有可能接受吗?...

说实话,我不知道你文章的表达水平如何。如果只是说这些结果的话,投BMC机率会大些,但也不敢保证。这个原来觉得很一般的杂志好像对于代谢产物鉴定没有创新的也不收,要求有PK数据。
6楼2012-09-07 21:02:36
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

letdd

新虫 (初入文坛)

引用回帖:
6楼: Originally posted by 独步青云 at 2012-09-07 21:02:36
说实话,我不知道你文章的表达水平如何。如果只是说这些结果的话,投BMC机率会大些,但也不敢保证。这个原来觉得很一般的杂志好像对于代谢产物鉴定没有创新的也不收,要求有PK数据。...

哦多谢指导
7楼2012-09-07 21:11:10
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

rockinuk

铁杆木虫 (职业作家)


小木虫: 金币+0.5, 给个红包,谢谢回帖
建议楼主好好针对那些专家的意见改改稿~~
若不改稿~~就改投其他地方吧~~
但会不会遇到类似情况~~很难说~~
我的爱徒~再撑一下~你快拿到清华全校优秀硕士论文了~
8楼2012-09-07 23:02:45
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

liuqingwang

金虫 (小有名气)


小木虫: 金币+0.5, 给个红包,谢谢回帖
楼主,你的投稿一审用了多久?我选的也是这个编辑,不知道靠谱不
9楼2012-10-26 09:43:06
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

小兵虾米

金虫 (正式写手)


小木虫: 金币+0.5, 给个红包,谢谢回帖
引用回帖:
9楼: Originally posted by liuqingwang at 2012-10-26 09:43:06
楼主,你的投稿一审用了多久?我选的也是这个编辑,不知道靠谱不

阁下的JPBA文章最后接受了没呢?一审用了多久啊
努力奋斗的宝妈
10楼2013-08-05 11:25:55
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 letdd 的主题更新
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[基金申请] 面上合作单位盖章 +5 ssyjh 2026-08-27 5/250 2026-08-27 20:50 by gdfollow
[基金申请] 青基如何破局 +6 lyz123lyz 2026-08-27 7/350 2026-08-27 17:31 by 宁静致远sy
[基金申请] 基金不中,共勉 +10 eulota 2026-08-26 10/500 2026-08-27 17:23 by lqllinqiaoli
[基金申请] 为什么 国际(地区)合作与交流项目 没有放榜? 10+3 majunge000 2026-08-26 11/550 2026-08-27 08:42 by 北京莱茵编辑
[硕博家园] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +3 LIbGuocjEEYw 2026-08-26 4/200 2026-08-27 02:01 by Ie9AyIAvGbvs
[基金申请] 范进中举一文的中心思想 +9 炎黄贵胄 2026-08-22 10/500 2026-08-26 15:40 by semaglutide
[基金申请] 2026年8月25日国自然放榜前突然收到列入评审专家邮件,有关系吗? +25 木水思豆 2026-08-25 28/1400 2026-08-26 14:53 by draco1987
[基金申请] 出来了 +9 trojank 2026-08-26 9/450 2026-08-26 14:25 by 宝贝虫子
[基金申请] 哪位高人中了,把查询到的截图贴出来让我看看,让我长长见识 +4 yuleib84 2026-08-26 5/250 2026-08-26 13:40 by yuleib84
[基金申请] 为什么国自然不能直接公布 +4 bjdxyxy 2026-08-26 4/200 2026-08-26 13:12 by qingmu1201
[基金申请] 国际合作可查了,中了面上 (EPI+1)(金币+50) +18 Ldrop2023 2026-08-26 18/900 2026-08-26 11:15 by cmrandy
[基金申请] 系统进不去 +4 yanglien 2026-08-26 5/250 2026-08-26 11:10 by wenfengw83
[基金申请] 今天务委会开完了,明天出结果吗 +19 angus9576 2026-08-25 23/1150 2026-08-26 10:03 by zp519
[基金申请] 国合现在查不到了吗? +10 chengyan1220 2026-08-24 20/1000 2026-08-26 08:57 by peasantsprig
[基金申请] 某些机构,以效率低为荣,以效率低作为存在感 +9 yuleib84 2026-08-25 10/500 2026-08-25 17:14 by alexon
[基金申请] 如果此刻你正在为国基感到焦虑,不妨来听听这首《基金之外》 +8 scalable 2026-08-24 8/400 2026-08-25 12:52 by jnhyjjm
[基金申请] 没有任何消息-是不是就凉了 +9 图啦图啦 2026-08-24 10/500 2026-08-25 11:59 by 南海小哥
[基金申请] 我面上完蛋了 +13 且听虎啸 2026-08-20 14/700 2026-08-25 09:10 by mrkang
[基金申请] 应该是下周三26日公布了吧? +4 哈哈蛤? 2026-08-21 4/200 2026-08-21 10:58 by Vivilian
[基金申请] 基金啊基金 +4 longfie172 2026-08-20 4/200 2026-08-21 08:58 by mark mao
信息提示
请填处理意见